Press Releases View More

  • Premier Recognized as Top 100 Bay Area Fastest Growing Businesses by San Francisco Business Times

    Posted on October 25th, 2012 @ 4:00 PM

    Premier Ranked #33 on the SF Business Times list of 100 Fastest Growing Bay Area Companies Read More

  • Inc. Magazine Unveils Its Annual Exclusive List of America’s Fastest-Growing Private Companies – the Inc. 500|5000

    Posted on September 10th, 2012 @ 12:00 AM

    Premier Ranks on the 2012 Inc. 500|5000 with Three-Year Sales Growth Read More

  • Premier Announces Corporate Sponsorship to La Casa de las Madres

    Posted on July 26th, 2012 @ 10:00 AM

    Premier supports La Casa de las Madres as they celebrate 35 Years of Transforming Lives Read More

Newsletters View More



Media & Awards View More



Industry News View More

  • Public to hear Presidio's three picks for former commissary site

    Posted on June 17th, 2013 @ 12:57 PM

    The Presidio Trust is hearing public presentations tonight from the three finalists chosen to redevelop the park’s former commissary site at Crissy Field. The Chora Group’s Bridge and Sustainability Institute, George Lucas’ Cultural Museum and the Golden Gate National Parks Conservancy’s Presidio Exchange will all make their case to the public before submitting final proposals in September. Last November, the Trust received 16 proposals to transform the site, now occupied by retailer Sports… Read More

  • Tech investor Michael Moritz knighted

    Posted on June 17th, 2013 @ 10:55 AM

    Michael Moritz, a partner at Sequoia Capital whose early investments in companies including Google, LinkedIn, YouTube and PayPal made him a billionaire, has been knighted by the Queen of England. Knighthood, according to the official website of the United Kingdom monarchy, recognizes "significant contributions to national life" and is regarded as one of the highest individual honors attainable in the United Kingdom. Though Moritz has been living in Silicon Valley for decades, he was born in Wales. BBC… Read More

  • NGM Biopharmaceuticals inks diabetes drug deal with AstraZeneca

    Posted on June 17th, 2013 @ 10:30 AM

    NGM Biopharmaceuticals Inc. will work with MedImmune, owned by giant AstraZeneca PLC, on drugs aimed at diabetes and obesity. South San Francisco-based NGM will contribute elements of its enteroendocrine cell, or ECC, program to the collaboration. Both MedImmune, based in Gaithersburg, Md., and NGM will work to test drug candidates under this deal, while MedImmune will have the option to license EEC targets from the research. MedImmune will also be responsible for developing, manufacturing and… Read More